Thyrocare Technologies · NSE: THYROCARE · BSE: 539871
Q1 FY19 results · Apr–Jun 2018
Thyrocare Technologies reported revenue from operations of ₹97.15 crore and net profit of ₹23.44 crore for Q1 FY19 (Apr–Jun 2018), on a consolidated basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 97.15 | — | — | — | — |
| Other income | 2.26 | — | — | — | — |
| Total income | 99.41 | — | — | — | — |
| Profit before tax | 37.67 | — | — | — | — |
| Net profit for the period | 23.44 | — | — | — | — |
| EPS, basic (₹) | 4.35 | — | — | — | — |
| Net margin (%) | 24.1 | — | — |
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 89.19 | — | — | — | — |
| Other income | 2.98 | — | — | — | — |
| Total income | 92.17 | — | — | — | — |
| Profit before tax | 38.93 | — | — | — | — |
| Net profit for the period | 25.38 | — | — | — | — |
| EPS, basic (₹) | 4.72 | — | — | — | — |
| Net margin (%) | 28.5 | — | — |
Consolidated
- Filed with BSE
- 17 Aug 2018, 15:39 IST
- Board meeting
- 11 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 17 Aug 2018, 15:39 IST
- Board meeting
- 11 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE